Shares of MediPharm Labs Corp. (TSE:LABS – Get Free Report) reached a new 52-week low during trading on Monday. The company traded as low as C$0.06 and last traded at C$0.06, with a volume of 123,354 shares trading hands. The stock had previously closed at C$0.07.
MediPharm Labs Price Performance
The company’s 50-day moving average is C$0.07 and its two-hundred day moving average is C$0.07. The company has a debt-to-equity ratio of 1.19, a current ratio of 2.69 and a quick ratio of 3.10. The firm has a market cap of C$25.63 million, a P/E ratio of -6.00 and a beta of -0.44.
MediPharm Labs Company Profile
Founded in 2015, MediPharm Labs specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API), and advanced derivative products produced in a GMP-certified facility with ISO-standard clean rooms. MediPharm has invested in an expert research-driven team, state-of-the-art technology, advanced purification methodologies, and purpose-built facilities to deliver pure, trusted, precision-dosed cannabinoid products for domestic and international markets.
Read More
- Five stocks we like better than MediPharm Labs
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
- GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
- Mortgage Rates Froze U.S. Housing, But These 3 Overseas Markets Still Pay Double Digits
- Big Tech Is Spending Billions on AI—These 5 Stocks Are Getting Paid
Receive News & Ratings for MediPharm Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediPharm Labs and related companies with MarketBeat.com's FREE daily email newsletter.
